Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy

被引:3
|
作者
Nunes, Jose Pedro L.
Costa, Ovidio
Faria, Maria do Sameiro
Almeida, Pedro Bernardo
Lacerda, Lucia
机构
[1] Univ Porto, Fac Med, P-4200 Oporto, Portugal
[2] Hosp Maria Pia, Oporto, Portugal
[3] Inst Radiol, Oporto, Portugal
[4] Inst Med Genet Jacinto Magalhaes, Enzymol Unit, Oporto, Portugal
来源
关键词
alpha-galactosidase A; Anderson-Fabry's disease; left ventricular hypertrophy;
D O I
10.1038/ncpcardio1012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A 64-year-old male was observed as an outpatient with atypical, non-exercise-induced chest pain and palpitations. He had arterial hypertension and marked concentric left ventricular hypertrophy. After 2.5 years of antihypertensive drug therapy the patient's blood pressure had returned to normal, but his left ventricular hypertrophy was unchanged. Investigations Electrocardiography, transthoracic echocardiography, myocardial perfusion scintigraphic imaging, measurement of a-galactosidase A activity, gene sequencing, brain MRI, carotid artery ultrasonography, biochemical renal evaluation and cardiac Doppler tissue imaging. Diagnosis Cardiac Fabry's disease. Management Losartan, hydrochlorothiazide, low-dose aspirin and bisoprolol. The patient is expected to begin enzyme replacement therapy.
引用
收藏
页码:630 / 633
页数:4
相关论文
共 50 条
  • [21] A rare cause of cardiac decompensation in a patient with left ventricular hypertrophy
    Mangner, Norman
    Gutberlet, Matthias
    Klingel, Karin
    Kandolf, Reinhard
    Schuler, Gerhard
    Linke, Axel
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (11) : 943 - 945
  • [22] A rare cause of cardiac decompensation in a patient with left ventricular hypertrophy
    Norman Mangner
    Matthias Gutberlet
    Karin Klingel
    Reinhard Kandolf
    Gerhard Schuler
    Axel Linke
    Clinical Research in Cardiology, 2012, 101 : 943 - 945
  • [23] Strategies of Screening for Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy
    Moiseev, Sergey
    Karovaikina, Ekaterina
    Moiseev, Alexey
    Bulanov, Nikolai
    Fomin, Victor
    MAYO CLINIC PROCEEDINGS, 2019, 94 (08) : 1644 - 1646
  • [24] Screening for Fabry Disease in Left Ventricular Hypertrophy: Documentation of a Novel Mutation
    Baptista, Ana
    Magalhaes, Pedro
    Leao, Slvia
    Carvalho, Sofia
    Mateus, Pedro
    Moreira, Ilidio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 105 (02) : 139 - 144
  • [25] PREVALENCE OF FABRY DISEASE IN KOREAN MALE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
    Kim, Woo-Shik
    Takenaka, Toshihiro
    Lee, Bang Hun
    Hong, Soon Pyo
    Park, Jong Chun
    Jeong, Jin-Won
    Ko, Jae Ki
    Choe, Kyung Hoon
    Kim, Jae Hyung
    Chung, Namsik
    Yoo, Han-Wook
    Tei, Chuwa
    Bae, Jong-Hoa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [26] Case Report Fabry Disease for Patients with unclear left ventricular Hypertrophy
    Buchacher, T.
    JOURNAL FUR KARDIOLOGIE, 2020, 27 (11-12): : 424 - 426
  • [27] Congress Report Left Ventricular Hypertrophy - Thinking about Fabry Disease
    Leitner, H.
    JOURNAL FUR KARDIOLOGIE, 2021, 28 (1-2): : 50 - 51
  • [28] Left ventricular hypertrophy depends on hemodynamic load in patients with Fabry disease
    Cocheteux, B
    Mousseaux, E
    de Féraudy, S
    Laurent, S
    Boutouyrie, P
    Germain, DP
    JOURNAL OF HYPERTENSION, 2004, 22 : S278 - S278
  • [29] Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy
    Terryn, Wim
    Deschoenmakere, Gert
    De Keyser, Jan
    Meersseman, Wouter
    Van Biesen, Wim
    Wuyts, Brigitte
    Hemelsoet, Dimitri
    Pascale, Hilbert
    De Backer, Julie
    De Paepe, An
    Poppe, Bruce
    Vanholder, Raymond
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (06) : 2555 - 2560
  • [30] Screening for Fabry disease in patients with left ventricular hypertrophy: preliminary results
    Gaspar, P.
    Azevedo, O.
    Rodrigues, D.
    Providencia, R.
    Gomes, P. Lourenco
    Monteiro, S.
    Brito, D.
    Miranda, M. C. Sa
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 : S61 - S62